Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products

NCT02768220 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT02768220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02768220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products
Lead sponsor
Northwell Health
Phase
Phase 4
Overall status
Withdrawn
Start date
December 1, 2017
Completion date
December 31, 2018
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced glycation end products, diabetes, sglt-2 inhibitors